Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
uproleselan (APL-106)
i
Other names:
APL-106, GMI-1271, GMI1271, GMI 1271
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Apollomics, GlycoMimetics
Drug class:
E-selectin antagonist
Related drugs:
‹
GMI-1687 (0)
GMI-1687 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
APL-106
Sensitive: B - Late Trials
APL-106
Sensitive
:
B
APL-106
Sensitive: B - Late Trials
APL-106
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.